Top Trending Tickers: Novo Nordisk, Walmart, and Barclays

Novo Nordisk (NVO)

Europe’s most valuable company, Novo Nordisk, witnesses a surge in shares after announcing a $2.3bn ($1.8bn) investment to ramp up the production of its popular weight loss drug, Wegovy, in France. This move is a response to high demand and investor concerns, with the Danish company set to add 500 jobs to the already existing 1,600. The massive investment mainly focuses on the production of diabetes drugs, cartridges, and vials, and is projected for completion by 2028. Moreover, the group plans a $6bn investment in production capacity and has also chosen Japan as the sixth country for Wegovy’s launch.

Walmart (WMT)

Walmart shares remain stagnant as investors anticipate US retailers’ performance in the holiday shopping season’s unofficial start, Black Friday. With a forecast of subdued consumer spending by the retail giant and the decision to remain closed on Thanksgiving, investors show concern over the future of US retail, especially amid economic challenges such as rising credit card debt and inflation. Meanwhile, Barclays reportedly aims to cut costs amounting to £1bn, potentially impacting up to 2,000 jobs.

Foot Locker (FL)

Fears loom as Foot Locker’s stock sees a decline in anticipation of a Q3 earnings miss. Despite a 40% year-to-date decline, the footwear retailer is projected to report underwhelming earnings and revenue figures. Analysts attribute such discrepancies to subpar consumer engagement, thus earning the company a sell rating and a low price target from UBS.

Download the Yahoo Finance app, available for Apple and Android.